Wound healing and tissue engineering
The present invention is directed to wound healing scaffolds cografted with a population of stem cells, wherein the population of stem cells are ABCB5+ stem cells. The scaffolds are, for instance, collagen glycosaminoglycan scaffolds.
1. A method for tissue engineering, comprising seeding a biological tissue scaffold with ABCB5(+) stem cells, maintaining the scaffold under conditions such that tissue is formed, and implanting the seeded scaffold at a site of a tissue defect,
wherein the scaffold is a porous matrix of cross-linked collagen and glycosaminoglycan and wherein the scaffold includes a separate semi-permeable layer,
wherein at least 99% of the total cells present in the scaffold are ABCB5(+) stem cells, and
wherein the ABCB5(+) stem cells are not treated with a soluble cytokine ex-vivo or in vitro prior to implantation.
2. The method of claim 1 , wherein the ABCB5+ stem cells are ABCB5+ dermal mesenchymal stem cells.
3. The method of claim 1 , wherein the ABCB5+ stem cells are ABCB5+ ocular stem cells.
4. The method of claim 1 , wherein the collagen glycosaminoglycan scaffold is selected from the group of materials consisting of chondroitin 6-sulfate, chondroitin 4-sulfate, heparin, heparin sulfate, keratan sulfate, dermatan sulfate, chitin and chitosan.
5. The method of claim 1 , wherein the collagen is bovine tendon collagen.
6. The method of claim 1 , wherein the semi-permeable layer is polysiloxane.
7. The method of claim 6 , wherein the scaffold is a Meshed Bilayer Wound Matrix.
8. The method of claim 1 , wherein the scaffold has a pore size of about 10-500 micrometers.
9. The method of claim 1 , wherein the scaffold has a pore size of about 50-350 micrometers.
10. The method of claim 1 , wherein the scaffold has a pore size of about 70-200 micrometers.